![]() ![]()
|
Bextra and the FDAIn view of the recent concerns over dangerous side effects of COX-2 selective drugs like Bextra, the FDA has mandated further studies. In addition, the FDA urges health care providers and patients to report adverse event information to FDA via the MedWatch program by phone (1-800-FDA-1088), or by fax (1-800-FDA-0178).
|
|||||||||||||||||||||||||||||||||||||